Format

Send to

Choose Destination
See comment in PubMed Commons below
Minerva Ginecol. 2013 Oct;65(5):497-504.

Androgen supplementation in IVF.

Author information

1
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, South Korea - chnkim@amc.seoul.kr.

Abstract

The desired objective of controlled ovarian stimulation (COS) is to allow the growth of a cohort of follicles and to facilitate the recovery of a large number of fertilizable oocytes. However, poor responders with diminished ovarian reserve often fail to respond adequately despite the maximal dose of gonadotropins administered, with the results that the number as well as quality of oocytes harvested may be very low, thereby decreasing the pregnancy rate in IVF cycles. Therefore, successful COS for poor responders remains to be a major challenge in IVF program. One of promising strategies for augmenting follicular recruitment in poor responders is androgen supplementation. However, there are limited data on androgen treatment for poor responders undergoing IVF. Therefore, well-designed larger studies with standardized methods are required.

PMID:
24096287
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Minerva Medica
    Loading ...
    Support Center